On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology - United Kingdom
doi 10.1517/17425255.2016.1141894
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa Healthcare

Related search

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Real-World Data on Nivolumab Treatment of Non-Small Cell Lung Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2016English

Non-Small Cell Lung Cancer

English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Inequalities in Non-Small Cell Lung Cancer Treatment and Mortality

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy